TreeWAS – Variant ID: rs3761218

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H52.1 Myopia	0.000	0.884	0.116
C48.1 Specified parts of peritoneum	0.000	0.935	0.065
C48.2 Peritoneum, unspecified	0.000	0.938	0.062
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.000	0.938	0.062
C48.0 Retroperitoneum	0.000	0.952	0.048
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.000	0.956	0.044
H52 Disorders of refraction and accommodation	0.000	0.965	0.035
H52.2 Astigmatism	0.000	0.970	0.030
H52.3 Anisometropia and aniseikonia	0.000	0.972	0.028
H52.6 Other disorders of refraction	0.000	0.974	0.026
H52.5 Disorders of accommodation	0.000	0.974	0.026
H52.4 Presbyopia	0.000	0.976	0.024
H52.7 Disorder of refraction, unspecified	0.000	0.979	0.021
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.983	0.017
T36-T50 Poisoning by drugs, medicaments and biological substances	0.016	0.984	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.015	0.985	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
T42.0 Hydantoin derivatives	0.015	0.985	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.015	0.985	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.015	0.985	0.000
T42.1 Iminostilbenes	0.014	0.986	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.014	0.986	0.000
T50.4 Drugs affecting uric acid metabolism	0.013	0.987	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.013	0.987	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.013	0.987	0.000
T38.1 Thyroid hormones and substitutes	0.013	0.987	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.013	0.987	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.013	0.987	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.987	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.013	0.987	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.013	0.987	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.013	0.987	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.987	0.013
T50.1 Loop [high-ceiling] diuretics	0.012	0.987	0.000
C46 Kaposi's sarcoma	0.000	0.987	0.012
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
T45.0 Antiallergic and antiemetic drugs	0.012	0.988	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.012	0.988	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.988	0.012
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.988	0.012
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.000	0.988	0.012
T41 Poisoning by anaesthetics and therapeutic gases	0.012	0.988	0.000
T42.3 Barbiturates	0.012	0.988	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.012	0.988	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.988	0.012
T38.5 Other oestrogens and progestogens	0.011	0.989	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.989	0.011
H52.0 Hypermetropia	0.000	0.989	0.011
T50.7 Analeptics and opioid receptor antagonists	0.011	0.989	0.000
T50.5 Appetite depressants	0.011	0.989	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.011	0.989	0.000
T50.0 Mineralocorticoids and their antagonists	0.011	0.989	0.000
C81 Hodgkin's disease	0.000	0.989	0.011
T42.5 Mixed antiepileptics, not elsewhere classified	0.011	0.989	0.000
T42.2 Succinimides and oxazolidinediones	0.011	0.989	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.011	0.989	0.000
T38.0 Glucocorticoids and synthetic analogues	0.011	0.989	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.011	0.989	0.000
T38.9 Other and unspecified hormone antagonists	0.011	0.989	0.000
T38.7 Androgens and anabolic congeners	0.011	0.989	0.000
T38.4 Oral contraceptives	0.011	0.989	0.000
T38.2 Antithyroid drugs	0.011	0.989	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
T44.0 Anticholinesterase agents	0.011	0.989	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.011	0.989	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.989	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.010	0.989	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.010	0.989	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.989	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.010	0.990	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.010	0.990	0.000
T40.3 Methadone	0.010	0.990	0.000
C81.0 Lymphocytic predominance	0.000	0.990	0.010
T40.5 Cocaine	0.010	0.990	0.000
C25.0 Head of pancreas	0.000	0.990	0.010
T48.5 Anti-common-cold drugs	0.010	0.990	0.000
T36 Poisoning by systemic antibiotics	0.010	0.990	0.000
C45 Mesothelioma	0.000	0.990	0.010
T40.6 Other and unspecified narcotics	0.010	0.990	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.010	0.990	0.000
T45.8 Other primarily systemic and haematological agents	0.010	0.990	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.010	0.990	0.000
T45.6 Fibrinolysis-affecting drugs	0.010	0.990	0.000
T45.4 Iron and its compounds	0.010	0.990	0.000
T45.3 Enzymes, not elsewhere classified	0.010	0.990	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990	0.000
T40.1 Heroin	0.010	0.990	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.010	0.990	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.010	0.990	0.000
T46.7 Peripheral vasodilators	0.010	0.990	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990	0.000
C49.4 Connective and soft tissue of abdomen	0.000	0.990	0.010
T50.8 Diagnostic agents	0.010	0.990	0.000
C81.7 Other Hodgkin's disease	0.000	0.990	0.009
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.990	0.009
T43.9 Psychotropic drug, unspecified	0.009	0.991	0.000
C49.3 Connective and soft tissue of thorax	0.000	0.991	0.009
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.009	0.991	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
T49.9 Topical agent, unspecified	0.009	0.991	0.000
T49.8 Other topical agents	0.009	0.991	0.000
T49.7 Dental drugs, topically applied	0.009	0.991	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.009	0.991	0.000
T49.5 Ophthalmological drugs and preparations	0.009	0.991	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.009	0.991	0.000
T49.3 Emollients, demulcents and protectants	0.009	0.991	0.000
T49.2 Local astringents and local detergents	0.009	0.991	0.000
T49.1 Antipruritics	0.009	0.991	0.000
T43.6 Psychostimulants with abuse potential	0.009	0.991	0.000
C49.0 Connective and soft tissue of head, face and neck	0.000	0.991	0.009
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.991	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.009	0.991	0.000
T48.4 Expectorants	0.009	0.991	0.000
T48.3 Antitussives	0.009	0.991	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.009	0.991	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.009	0.991	0.000
T48.0 Oxytocic drugs	0.009	0.991	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.991	0.009
T43.0 Tricyclic and tetracyclic antidepressants	0.009	0.991	0.000
C46.9 Kaposi's sarcoma, unspecified	0.000	0.991	0.009
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.991	0.009
C46.7 Kaposi's sarcoma of other sites	0.000	0.991	0.009
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.991	0.009
C46.2 Kaposi's sarcoma of palate	0.000	0.991	0.009
C46.1 Kaposi's sarcoma of soft tissue	0.000	0.991	0.009
C46.0 Kaposi's sarcoma of skin	0.000	0.991	0.009
K50.1 Crohn's disease of large intestine	0.000	0.991	0.009
T43.8 Other psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.991	0.000
T40.8 Lysergide [LSD]	0.009	0.991	0.000
T40.7 Cannabis (derivatives)	0.009	0.991	0.000
T40.0 Opium	0.009	0.991	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.009	0.991	0.000
T41.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.991	0.009
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.000	0.991	0.009
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.000	0.991	0.009
C47.6 Peripheral nerves of trunk, unspecified	0.000	0.991	0.009
C47.5 Peripheral nerves of pelvis	0.000	0.991	0.009
C47.4 Peripheral nerves of abdomen	0.000	0.991	0.009
C47.3 Peripheral nerves of thorax	0.000	0.991	0.009
C47.2 Peripheral nerves of lower limb, including hip	0.000	0.991	0.009
C47.0 Peripheral nerves of head, face and neck	0.000	0.991	0.009
T43.5 Other and unspecified antipsychotics and neuroleptics	0.009	0.991	0.000
T41.5 Therapeutic gases	0.009	0.991	0.000
T41.4 Anaesthetic, unspecified	0.009	0.991	0.000
T41.3 Local anaesthetics	0.009	0.991	0.000
T41.1 Intravenous anaesthetics	0.009	0.991	0.000
T41.0 Inhaled anaesthetics	0.009	0.991	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.991	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.991	0.009
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.991	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.991	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.991	0.000
T37.5 Antiviral drugs	0.008	0.991	0.000
T37.4 Anthelminthics	0.008	0.991	0.000
T37.3 Other antiprotozoal drugs	0.008	0.991	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.991	0.000
T37.1 Antimycobacterial drugs	0.008	0.991	0.000
T37.0 Sulphonamides	0.008	0.991	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.991	0.008
C81.2 Mixed cellularity	0.000	0.992	0.008
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.992	0.008
C81.3 Lymphocytic depletion	0.000	0.992	0.008
C85.0 Lymphosarcoma	0.000	0.992	0.008
C47.1 Peripheral nerves of upper limb, including shoulder	0.000	0.992	0.008
T47.6 Antidiarrhoeal drugs	0.008	0.992	0.000
C45.7 Mesothelioma of other sites	0.000	0.992	0.008
T47.2 Stimulant laxatives	0.008	0.992	0.000
C81.1 Nodular sclerosis	0.000	0.992	0.008
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.008	0.992	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.008	0.992	0.000
T47.7 Emetics	0.008	0.992	0.000
T47.5 Digestants	0.008	0.992	0.000
T47.3 Saline and osmotic laxatives	0.008	0.992	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
C71.9 Brain, unspecified	0.008	0.992	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.008	0.992	0.000
T36.4 Tetracyclines	0.008	0.992	0.000
T36.0 Penicillins	0.008	0.992	0.000
T40.4 Other synthetic narcotics	0.008	0.992	0.000
T36.9 Systemic antibiotic, unspecified	0.007	0.992	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.992	0.000
T36.6 Rifamycins	0.007	0.992	0.000
T36.5 Aminoglycosides	0.007	0.992	0.000
T36.2 Chloramphenicol group	0.007	0.992	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.992	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.992	0.008
C71.3 Parietal lobe	0.007	0.992	0.000
C45.2 Mesothelioma of pericardium	0.000	0.993	0.007
C45.1 Mesothelioma of peritoneum	0.000	0.993	0.007
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.993	0.007
T45.5 Anticoagulants	0.007	0.993	0.000
T47.4 Other laxatives	0.007	0.993	0.000
C71 Malignant neoplasm of brain	0.007	0.993	0.000
M95.0 Acquired deformity of nose	0.000	0.993	0.007
C25 Malignant neoplasm of pancreas	0.000	0.993	0.007
T36.8 Other systemic antibiotics	0.007	0.993	0.000
M25.56 Pain in joint (Lower leg)	0.007	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
S42.40 Fracture of lower end of humerus (closed)	0.007	0.993	0.000
I82.2 Embolism and thrombosis of vena cava	0.000	0.993	0.007
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.993	0.006
C83.3 Large cell (diffuse)	0.000	0.993	0.007
C71.0 Cerebrum, except lobes and ventricles	0.006	0.993	0.000
T36.3 Macrolides	0.006	0.993	0.000
C88 Malignant immunoproliferative diseases	0.000	0.994	0.006
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.994	0.006
C49.5 Connective and soft tissue of pelvis	0.000	0.994	0.006
T46.1 Calcium-channel blockers	0.006	0.994	0.000
C45.0 Mesothelioma of pleura	0.000	0.994	0.006
C25.9 Pancreas, unspecified	0.000	0.994	0.006
T43.2 Other and unspecified antidepressants	0.006	0.994	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.006	0.994	0.000
C71.2 Temporal lobe	0.006	0.994	0.000
C25.4 Endocrine pancreas	0.000	0.994	0.006
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.994	0.006
C45.9 Mesothelioma, unspecified	0.000	0.994	0.006
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.994	0.006
C25.8 Overlapping lesion of pancreas	0.000	0.994	0.006
C71.7 Brain stem	0.006	0.994	0.000
R87.6 Abnormal cytological findings	0.006	0.994	0.000
B02.9 Zoster without complication	0.000	0.994	0.006
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.994	0.005
C71.6 Cerebellum	0.005	0.994	0.000
C94 Other leukaemias of specified cell type	0.000	0.994	0.005
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.994	0.005
C95 Leukaemia of unspecified cell type	0.000	0.995	0.005
C90.0 Multiple myeloma	0.000	0.995	0.005
C71.8 Overlapping lesion of brain	0.005	0.995	0.000
C25.1 Body of pancreas	0.000	0.995	0.005
C90.1 Plasma cell leukaemia	0.000	0.995	0.005
Z22.3 Carrier of other specified bacterial diseases	0.000	0.995	0.005
C25.3 Pancreatic duct	0.000	0.995	0.005
R47.1 Dysarthria and anarthria	0.005	0.995	0.000
C25.7 Other parts of pancreas	0.000	0.995	0.005
C71.4 Occipital lobe	0.005	0.995	0.000
C90.3 Solitary plasmacytoma	0.000	0.995	0.005
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.000	0.995	0.005
C86 Other specified types of T/NK-cell lymphoma	0.000	0.995	0.005
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.995	0.005
M47.96 Spondylosis, unspecified (Lumbar region)	0.005	0.995	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.000	0.995	0.005
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.995	0.005
C93 Monocytic leukaemia	0.000	0.995	0.005
C25.2 Tail of pancreas	0.000	0.995	0.005
C71.5 Cerebral ventricle	0.005	0.995	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.995	0.005
C88.7 Other malignant immunoproliferative diseases	0.000	0.995	0.005
C88.3 Immunoproliferative small intestinal disease	0.000	0.995	0.005
C88.2 Gamma heavy chain disease	0.000	0.995	0.005
C88.1 Alpha heavy chain disease	0.000	0.995	0.005
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.000	0.995	0.005
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.000	0.995	0.005
C83.5 Lymphoblastic (diffuse)	0.000	0.995	0.004
R47.0 Dysphasia and aphasia	0.005	0.995	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.996	0.004
C83.4 Immunoblastic (diffuse)	0.000	0.996	0.004
C83.2 Mixed small and large cell (diffuse)	0.000	0.996	0.004
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.996	0.004
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.000	0.996	0.004
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.996	0.004
C96.8 Histiocytic sarcoma	0.000	0.996	0.004
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.996	0.004
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.996	0.004
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.996	0.004
C96.3 True histiocytic lymphoma	0.000	0.996	0.004
C96.2 Malignant mast cell tumour	0.000	0.996	0.004
C96.1 Malignant histiocytosis	0.000	0.996	0.004
C96.0 Letterer-Siwe disease	0.000	0.996	0.004
R87 Abnormal findings in specimens from female genital organs	0.004	0.996	0.000
S05 Injury of eye and orbit	0.000	0.996	0.004
L40.9 Psoriasis, unspecified	0.000	0.996	0.004
C84.5 Other and unspecified T-cell lymphomas	0.000	0.996	0.004
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.996	0.004
C94.7 Other specified leukaemias	0.000	0.996	0.004
C94.5 Acute myelofibrosis	0.000	0.996	0.004
C94.4 Acute panmyelosis	0.000	0.996	0.004
C94.3 Mast cell leukaemia	0.000	0.996	0.004
C94.2 Acute megakaryoblastic leukaemia	0.000	0.996	0.004
C94.1 Chronic erythraemia	0.000	0.996	0.004
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.996	0.004
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.996	0.004
C95.7 Other leukaemia of unspecified cell type	0.000	0.996	0.004
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.996	0.004
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.996	0.004
C95.9 Leukaemia, unspecified	0.000	0.996	0.004
C83.1 Small cleaved cell (diffuse)	0.000	0.996	0.004
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.996	0.004
C86.4 Blastic NK-cell lymphoma	0.000	0.996	0.004
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.996	0.004
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.996	0.004
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.996	0.004
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.996	0.004
S05.1 Contusion of eyeball and orbital tissues	0.000	0.996	0.004
M95.2 Other acquired deformity of head	0.000	0.996	0.004
C91.1 Chronic lymphocytic leukaemia	0.004	0.996	0.000
S05.9 Injury of eye and orbit, part unspecified	0.000	0.996	0.004
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.000	0.996	0.004
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.000	0.996	0.004
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.000	0.996	0.004
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.000	0.996	0.004
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.996	0.004
C71.1 Frontal lobe	0.004	0.996	0.000
S70.0 Contusion of hip	0.004	0.996	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.996	0.004
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.996	0.004
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.996	0.004
C84.3 Lymphoepithelioid lymphoma	0.000	0.996	0.004
C84.2 T-zone lymphoma	0.000	0.996	0.004
C84.1 Sezary's diease	0.000	0.996	0.004
C93.9 Monocytic leukaemia, unspecified	0.000	0.996	0.004
C93.7 Other monocytic leukaemia	0.000	0.996	0.004
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.996	0.004
C93.2 Subacute monocytic leukaemia	0.000	0.996	0.004
C93.0 Acute monocytic leukaemia	0.000	0.996	0.004
C95.0 Acute leukaemia of unspecified cell type	0.000	0.996	0.004
S05.6 Penetrating wound of eyeball without foreign body	0.000	0.996	0.004
C90.2 Plasmacytoma, extramedullary	0.000	0.996	0.004
S70.9 Superficial injury of hip and thigh, unspecified	0.004	0.996	0.000
C83.7 Burkitt's tumour	0.000	0.996	0.004
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.004	0.996	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.996	0.004
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.996	0.004
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.996	0.003
S05.5 Penetrating wound of eyeball with foreign body	0.000	0.996	0.004
C92 Myeloid leukaemia	0.000	0.996	0.004
S70 Superficial injury of hip and thigh	0.004	0.996	0.000
M95.3 Acquired deformity of neck	0.000	0.996	0.004
R47 Speech disturbances, not elsewhere classified	0.004	0.996	0.000
C84.0 Mycosis fungoides	0.000	0.996	0.003
I35.2 Aortic (valve) stenosis with insufficiency	0.004	0.996	0.000
M95.4 Acquired deformity of chest and rib	0.000	0.996	0.004
C84.4 Peripheral T-cell lymphoma	0.000	0.996	0.003
R87.5 Abnormal microbiological findings	0.004	0.996	0.000
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.000	0.996	0.003
M95.8 Other specified acquired deformities of musculoskeletal system	0.000	0.996	0.003
M95.5 Acquired deformity of pelvis	0.000	0.996	0.003
R89 Abnormal findings in specimens from other organs, systems and tissues	0.004	0.996	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.996	0.003
M95.1 Cauliflower ear	0.000	0.996	0.003
S05.4 Penetrating wound of orbit with or without foreign body	0.000	0.996	0.003
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.000	0.996	0.003
R87.0 Abnormal level of enzymes	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.000	0.997	0.003
C93.1 Chronic monocytic leukaemia	0.000	0.997	0.003
R87.9 Unspecified abnormal finding	0.003	0.997	0.000
R87.8 Other abnormal findings	0.003	0.997	0.000
R87.4 Abnormal immunological findings	0.003	0.997	0.000
R87.3 Abnormal level of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
R87.2 Abnormal level of other drugs, medicaments and biological substances	0.003	0.997	0.000
R87.1 Abnormal level of hormones	0.003	0.997	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.997	0.003
K70.3 Alcoholic cirrhosis of liver	0.000	0.997	0.003
S05.7 Avulsion of eye	0.000	0.997	0.003
S70.7 Multiple superficial injuries of hip and thigh	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.003
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.003	0.997	0.000
R85.5 Abnormal microbiological findings	0.003	0.997	0.000
S79.9 Unspecified injury of hip and thigh	0.003	0.997	0.000
R89.0 Abnormal level of enzymes	0.003	0.997	0.000
T42.4 Benzodiazepines	0.003	0.997	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.003	0.997	0.000
K70.1 Alcoholic hepatitis	0.000	0.997	0.003
L50.0 Allergic urticaria	0.000	0.997	0.003
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.002	0.997	0.001
S32.00 Fracture of lumbar vertebra (closed)	0.003	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.000	0.997	0.003
R89.7 Abnormal histological findings	0.003	0.997	0.000
R89.6 Abnormal cytological findings	0.003	0.997	0.000
S05.8 Other injuries of eye and orbit	0.000	0.997	0.003
R89.5 Abnormal microbiological findings	0.003	0.997	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.997	0.003
C92.4 Acute promyelocytic leukaemia	0.000	0.997	0.003
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.997	0.003
Y43.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
C92.9 Myeloid leukaemia, unspecified	0.000	0.997	0.003
R89.9 Unspecified abnormal finding	0.003	0.997	0.000
S32.0 Fracture of lumbar vertebra	0.003	0.997	0.000
Z46.2 Fitting and adjustment of other devices related to nervous system and special senses	0.003	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.997	0.003
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.997	0.003
C92.3 Myeloid sarcoma	0.000	0.997	0.003
S70.8 Other superficial injuries of hip and thigh	0.003	0.997	0.000
H51 Other disorders of binocular movement	0.000	0.997	0.003
S32 Fracture of lumbar spine and pelvis	0.003	0.997	0.000
M25.59 Pain in joint (Site unspecified)	0.003	0.997	0.000
S70.1 Contusion of thigh	0.003	0.997	0.000
M95.96 Acquired deformity of musculoskeletal system, unspecified	0.000	0.997	0.003
K70 Alcoholic liver disease	0.000	0.997	0.003
R89.8 Other abnormal findings	0.003	0.997	0.000
R89.3 Abnormal level of substances chiefly nonmedicinal as to source	0.003	0.997	0.000
R89.2 Abnormal level of other drugs, medicaments and biological substances	0.003	0.997	0.000
R89.1 Abnormal level of hormones	0.003	0.997	0.000
S79 Other and unspecified injuries of hip and thigh	0.003	0.997	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.003	0.997	0.000
M25.54 Pain in joint (Hand)	0.003	0.997	0.000
R89.4 Abnormal immunological findings	0.003	0.997	0.000
S79.8 Other specified injuries of hip and thigh	0.003	0.997	0.000
S32.1 Fracture of sacrum	0.003	0.997	0.000
S32.10 Fracture of sacrum (closed)	0.003	0.997	0.000
R83 Abnormal findings in cerebrospinal fluid	0.003	0.997	0.000
R85.9 Unspecified abnormal finding	0.003	0.997	0.000
M50.1 Cervical disk disorder with radiculopathy	0.003	0.997	0.000
R85.6 Abnormal cytological findings	0.003	0.997	0.000
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.000	0.997	0.003
K81.9 Cholecystitis, unspecified	0.000	0.997	0.003
R87.7 Abnormal histological findings	0.002	0.997	0.000
S32.3 Fracture of ilium	0.003	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.000	0.997	0.002
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
J86.9 Pyothorax without fistula	0.000	0.997	0.003
S32.7 Multiple fractures of lumbar spine and pelvis	0.003	0.997	0.000
H51.2 Internuclear ophthalmoplegia	0.000	0.997	0.002
S32.5 Fracture of pubis	0.003	0.997	0.000
Y43 Primarily systemic agents	0.000	0.997	0.003
R85.4 Abnormal immunological findings	0.002	0.997	0.000
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.997	0.000
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.997	0.000
R85.1 Abnormal level of hormones	0.002	0.997	0.000
R85.0 Abnormal level of enzymes	0.002	0.997	0.000
C83.0 Small cell (diffuse)	0.000	0.997	0.002
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.997	0.001
C91.7 Other lymphoid leukaemia	0.001	0.997	0.001
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.997	0.001
C91.3 Prolymphocytic leukaemia	0.001	0.997	0.001
C91.2 Subacute lymphocytic leukaemia	0.001	0.997	0.001
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.002	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.000	0.997	0.002
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.997	0.002
M76.67 Achilles tendinitis (Ankle and foot)	0.000	0.997	0.002
S32.4 Fracture of acetabulum	0.002	0.997	0.000
C91.5 Adult T-cell leukaemia	0.001	0.998	0.001
S32.30 Fracture of ilium (closed)	0.002	0.998	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
V49.9 Car occupant [any] injured in unspecified traffic accident	0.002	0.998	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
S32.01 Fracture of lumbar vertebra (open)	0.002	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
K70.0 Alcoholic fatty liver	0.000	0.998	0.002
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.001
S42.4 Fracture of lower end of humerus	0.002	0.998	0.000
H51.1 Convergence insufficiency and excess	0.000	0.998	0.002
H51.0 Palsy of conjugate gaze	0.000	0.998	0.002
R86 Abnormal findings in specimens from male genital organs	0.002	0.998	0.000
H51.8 Other specified disorders of binocular movement	0.000	0.998	0.002
S32.2 Fracture of coccyx	0.002	0.998	0.000
R83.5 Abnormal microbiological findings	0.002	0.998	0.000
R85.7 Abnormal histological findings	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
K70.4 Alcoholic hepatic failure	0.000	0.998	0.002
L40.4 Guttate psoriasis	0.000	0.998	0.002
D43.2 Brain, unspecified	0.002	0.998	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.998	0.002
R85.8 Other abnormal findings	0.002	0.998	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.002	0.998	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
M43.09 Spondylolysis (Site unspecified)	0.002	0.998	0.000
S79.7 Multiple injuries of hip and thigh	0.002	0.998	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
V89.9 Person injured in unspecified vehicle accident	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.001	0.998	0.001
C91.0 Acute lymphoblastic leukaemia	0.001	0.998	0.001
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.998	0.002
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.002	0.998	0.000
M46 Other inflammatory spondylopathies	0.000	0.998	0.002
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.002	0.998	0.000
S32.11 Fracture of sacrum (open)	0.002	0.998	0.000
I82 Other venous embolism and thrombosis	0.000	0.998	0.002
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.998	0.002
H51.9 Disorder of binocular movement, unspecified	0.000	0.998	0.002
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
F33 Recurrent depressive disorder	0.000	0.998	0.002
R84 Abnormal findings in specimens from respiratory organs and thorax	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.998	0.002
R83.9 Unspecified abnormal finding	0.002	0.998	0.000
R83.7 Abnormal histological findings	0.002	0.998	0.000
R83.6 Abnormal cytological findings	0.002	0.998	0.000
R83.4 Abnormal immunological findings	0.002	0.998	0.000
R83.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R83.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R83.1 Abnormal level of hormones	0.002	0.998	0.000
R83.0 Abnormal level of enzymes	0.002	0.998	0.000
L40 Psoriasis	0.000	0.998	0.002
S32.40 Fracture of acetabulum (closed)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations